调心汤治疗冠心病PCI术围手术期焦虑的疗效观察  

Clinical Observation of Tiaoxintang on perioperative anxiety in patients treated with PCI

作　　者：梁田 张庆 

机构地区：[1]江苏省徐州市中医心内科,江苏徐州221003

出　　处：《河南中医》2014年第B11期15-15,共1页Henan Traditional Chinese Medicine

摘　　要：目的研究冠心病患者接受PCI 术围手术期焦虑状况,使用自拟中药调心汤予以抗焦虑治疗,观察其疗效及安全性.方法：将68 例冠心病行PCI 术患者,予以术前及术后SAS 评分,并将患者随机分为治疗组和对照组各34 例,两组均接受常规治疗和PCI 术,治疗组同时口服调心汤125ml,BID,采用焦虑自评量表（SAS）和临床资料调查表等,于治疗前后5 天进行评估分析.结果：治疗组患者的手术成功率与对照组相同,治疗组焦虑明显缓解,有统计学意义,治疗组患者临床疗效好于对照组,但无统计学差异,并无明显发症.结论：冠心病PCI 围手术期患者使用中药调心汤,抗焦虑明显,可改善患者心绞痛症状,使用无明显副作用.ObjectiveTo study perioperative anxiety in patients with coronary heart disease（CHD ）before and after the PCI therapy, and to investigate the clinical efficacy andsecurity of Chinese medicine tiaoxintang in the treatment of perioperative anxiety in patients treated with PCI. Methods： 68 patients with CHD were investigated and assessed withSAS before and after the operation of PCI, 68 cases were randomly divided into treatment group （n=34） and control group （n=34）. Both groups received routine therapy and PCI, butthe patients in the treatment group received tiaoxintang orl 125ml bid, SAS was used to evaluate the patients for 5 days before and after therapy. Results：Two groups are anxietyseriously before the operation. After therapy, compared with the control group, the SAS quantity value of treatment group have marked difference （P〈0.05）. The clinical efficacy oftreatment group is better than control group. The complications between two groups have no significant difference. Conclusion：Traditional Chinese medicine tiaoxintang is aneffective medicine to reduce the anxiety in patients with CHD who receive the PCI, and improve patient’s clinical efficacy, it has no insignificant side efficacy.

关 键 词：冠心病 介入治疗 围手术期焦虑 中药 

分 类 号：R541.4[医药卫生—心血管疾病]